JURGI CAMBLONG reports multiple 10b5-1 sales

JURGI CAMBLONG reported multiple sales of Common stock executed under a 10b5-1 plan, with transaction entries listed through 06/26/2026.

Rhea-AI Filing Summary

JURGI CAMBLONG reported multiple sales of Common stock executed under a 10b5-1 plan, with transaction entries listed through 06/26/2026. The filing lists a separate line showing 20,000 shares described as "Securities To Be Sold" and multiple executed sales by date and amount.

The entries include a largest listed sale of 50,069 shares on 06/26/2026 (proceeds $290,329.01) and several earlier 10b5-1 dispositions in April–June 2026. The filing names Morgan Stanley Smith Barney LLC in the filer/issuer section.

Insights

Equity Transactions Analyst

Multiple scheduled 10b5-1 sales were reported, with detailed per-trade entries through 06/26/2026.

The excerpt lists a manifested plan of brokered dispositions and executed trades attributed to JURGI CAMBLONG, including a separate line showing 20,000 shares as "Securities To Be Sold." The largest trade shown is 50,069 shares on 06/26/2026 for $290,329.01.

Timing and cash recipients are implied by the per-trade proceeds but the filing does not specify broader proceeds treatment or any change in ownership structure; subsequent regulatory filings or brokerage confirmations would show final cash-flow allocation.

Key Figures

Securities To Be Sold: 20,000 shares Largest reported trade: 50,069 shares Proceeds for 06/26/2026 trade: $290,329.01 +2 more

5 metrics

Securities To Be Sold 20,000 shares listed in filer/issuer summary

Largest reported trade 50,069 shares trade dated <date>06/26/2026</date>

Proceeds for 06/26/2026 trade $290,329.01 06/26/2026 sale of 50,069 shares

Other executed trade example 43,129 shares trade dated <date>04/14/2026</date> with proceeds <money>$213,833.58</money>

Example smaller sale 1,373 shares trade dated <date>06/25/2026</date> proceeds <money>$7,826.10</money>

Key Terms

10b5-1, Form 144, Founders Shares

3 terms

10b5-1 regulatory

"Entries labeled "10b5-1 Sales" that list dates, shares, and proceeds"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Header and metadata identifying the filing type as 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founders Shares market

"Line reading "Founders Shares | Issuer | 20000 | 03/18/2021""

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions does SOPH's Form 144 show for JURGI CAMBLONG?

The Form 144 lists multiple 10b5-1 sales by JURGI CAMBLONG dated April–June 2026, including a 50,069-share sale on 06/26/2026 for $290,329.01. It also shows a separate "Securities To Be Sold" line of 20,000 shares.

Who is named as the broker or filer on the Form 144 for SOPH?

The excerpt names Morgan Stanley Smith Barney LLC at an address in New York on the filing cover. This broker entry appears in the filer/issuer information section of the provided excerpt.

Are the reported trades executed under a pre-arranged trading plan?

Yes. Each trade entry is labeled as a 10b5-1 Sale, indicating execution under a pre-established trading plan. The filing lists individual trade dates, share counts, and proceeds for those plan-based dispositions.

Does the filing specify how proceeds are used or who receives them?

The listed trades include per-trade proceeds (e.g., $290,329.01) but the excerpt does not state who receives the proceeds or any use-of-proceeds designation; cash-flow allocation is not disclosed in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	JURGI CAMBLONG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	115000.00	71790366	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2021	Founders Shares	Issuer			20000	03/18/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/26/2026	50069	290329.01
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/25/2026	1373	7826.10
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/10/2026	8500	44500.90
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	4486	20657.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/11/2026	8500	43241.20
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/20/2026	4486	23349.63
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/15/2026	17473	87401.69
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/14/2026	43129	213833.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/13/2026	4399	20957.28
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/10/2026	12232	57710.79
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/09/2026	1950	9243.78
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/08/2026	2800	13553.12
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/07/2026	2500	12154.75
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/06/2026	2600	12614.42

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jurgi Camblong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)